Literature DB >> 9179563

Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol.

G Chevalier1, P Benard, H Cousse, T Bengone.   

Abstract

The study carried out on rats given orally the n-hexane lipido/sterolic extract of Serenoa repens (LSESR), supplemented with [14C]-labelled oleic or lauric acids or beta-sitosterol, demonstrated that radioactivity uptake in prostatic tissues shows the highest level in the case of administration of LSESR supplemented with [14C]-labelled oleic acid. This was clearly demonstrated on a rat with an induced fibro-muscular hyperplasia of the prostate and by quantitative measurements of radioactivity. Ratios of radioactivity in tissues compared to plasma show an uptake of radioactivity greater in prostate as compared to other genital organs, i.e. the seminal vesicles or to other organs such as liver.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179563     DOI: 10.1007/BF03189787

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Studies on the distribution and fate of S35-labelled benzylpenicillin in the body.

Authors:  S ULLBERG
Journal:  Acta Radiol Suppl       Date:  1954

2.  [Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism].

Authors:  W Breu; M Hagenlocher; K Redl; G Tittel; F Stadler; H Wagner
Journal:  Arzneimittelforschung       Date:  1992-04

3.  [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].

Authors:  A Tasca; M Barulli; A Cavazzana; F Zattoni; W Artibani; F Pagano
Journal:  Minerva Urol Nefrol       Date:  1985 Jan-Mar       Impact factor: 3.720

4.  [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].

Authors:  J Ollé Carreras
Journal:  Arch Esp Urol       Date:  1987-06       Impact factor: 0.436

5.  Sites of steroid hormone formation. Autoradiographic studies using labelled precursors.

Authors:  L E Appelgren
Journal:  Acta Physiol Scand Suppl       Date:  1967

6.  The Lipidosterolic Extract fromSerenoa repens Interferes with Prolactin Receptor Signal Transduction.

Authors:  P. Vacher; N. Prevarskaya; R. Skryma; M.C. Audy; A.M. Vacher; M.F. Odessa; B. Dufy
Journal:  J Biomed Sci       Date:  1995-10       Impact factor: 8.410

7.  [Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr].

Authors:  J P Tarayre; A Delhon; H Lauressergues; A Stenger; M Barbara; M Bru; G Villanova; V Caillol; M Aliaga
Journal:  Ann Pharm Fr       Date:  1983

8.  A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

Authors:  G Champault; J C Patel; A M Bonnard
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 9.  Autoradiographic studies with fatty acids and some other lipids: a review.

Authors:  W Becker; A Bruce
Journal:  Prog Lipid Res       Date:  1985       Impact factor: 16.195

10.  Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.

Authors:  E Carilla; M Briley; F Fauran; C Sultan; C Duvilliers
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

View more
  6 in total

Review 1.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

2.  Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.

Authors:  L Yohani Pérez; Roberto Menéndez; Rosa Más; Rosa M González
Journal:  Curr Ther Res Clin Exp       Date:  2006-11

Review 3.  Pharmacological effects of saw palmetto extract in the lower urinary tract.

Authors:  Mayumi Suzuki; Yoshihiko Ito; Tomomi Fujino; Masayuki Abe; Keizo Umegaki; Satomi Onoue; Hiroshi Noguchi; Shizuo Yamada
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

4.  Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure.

Authors:  Paolo Governa; Daniela Giachetti; Marco Biagi; Fabrizio Manetti; Luca De Vico
Journal:  PeerJ       Date:  2016-11-22       Impact factor: 2.984

5.  Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil.

Authors:  Andrea Fratter; Vera Mason; Marzia Pellizzato; Stefano Valier; Arrigo Francesco Giuseppe Cicero; Erik Tedesco; Elisa Meneghetti; Federico Benetti
Journal:  Int J Mol Sci       Date:  2019-02-04       Impact factor: 5.923

Review 6.  Hexanic Extract of Serenoa repens (Permixon®): A Review in Symptomatic Benign Prostatic Hyperplasia.

Authors:  Hannah A Blair
Journal:  Drugs Aging       Date:  2022-03-03       Impact factor: 4.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.